You are required to be logged in to access the full website
Click here if you have forgotten your username or password
Therapy Areas
21 October 2025 - Swedish biotechnology company Alligator Bioscience AB (STO:ATORX) announced on Tuesday that the US Patent and Trademark Office has granted US Patent No. 12,448,465 covering ATOR-4066, its bispecific antibody targeting CD40 and CEACA...
21 October 2025 - Citius Oncology Inc (Nasdaq:CTOR), the oncology-focused subsidiary of Citius Pharmaceuticals Inc (Nasdaq:CTXR), announced on Monday that it has entered into a distribution services agreement with McKesson Corporation (NYSE:MCK), a p...
21 October 2025 - Cumberland Pharmaceuticals Inc (Nasdaq:CPIX), a US-based specialty pharmaceutical company, announced on Monday that it has entered into strategic arrangements with RedHill Biopharma Ltd (Nasdaq: RDHL), an Israeli specialty biopharma...
21 October 2025 - The Lupus Foundation of America Inc reported on Monday that the US Food and Drug Administration (FDA) has approved Gazyva (obinutuzumab), developed by biotechnology company Genentech, a member of the Roche Group (SIX: RO, ROG) (OTCQ...
20 October 2025 - US pharmaceutical company Merck & Co Inc (NYSE:MRK), known as MSD outside the US and Canada, on Monday announced new long-term data demonstrating sustained survival benefits of Keytruda (pembrolizumab) in patients with non-small...
20 October 2025 - French biotech company Transgene (Euronext Paris:TNG) and Swedish biotech company BioInvent International AB (STO:BINV) on Monday presented new clinical data at the 2025 European Society for Medical Oncology (ESMO) Annual Meeting sh...
20 October 2025 - French healthcare company Sanofi S.A. (Euronext Paris:SAN) (Nasdaq:SNY) on Monday announced new results from the FLUNITY-HD study, published in The Lancet, confirming that its high-dose influenza vaccine, Efluelda (Fluzone High-Dose...